盐皮质激素受体拮抗剂-话题@MedSci

#盐皮质激素受体拮抗剂#

16篇内容 | 1506人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2266065, encodeId=dcfe22660656f, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> <a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a> <a href='/topic/show?id=b24e10e628bb' target=_blank style='color:#2F92EE;'>#不良心血管事件（MACE）#</a>, objectTitle=Esc Heart Fail.：中国学者证实盐皮质激素受体拮抗剂在不同疾病条件下具有不同的心血管保护作用, objectType=article, longId=878268, objectId=8faf8e826813, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720691758183_92910.jpg, objectUrl=/article/show_article.do?id=8faf8e826813, replyNumber=0, likeNumber=28, createdTime=2025-05-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8faf8e826813, moduleTitle=Esc Heart Fail.：中国学者证实盐皮质激素受体拮抗剂在不同疾病条件下具有不同的心血管保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8faf8e826813)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2180444, encodeId=e7f42180444fa, content=<a href='/topic/show?id=737a54248f5' target=_blank style='color:#2F92EE;'>#房颤#</a> <a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Eur Heart J：盐皮质激素受体拮抗剂与房颤的关系, objectType=article, longId=808703, objectId=64c0808e0384, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240109/1704810722021_1739456.jpg, objectUrl=/article/show_article.do?id=64c0808e0384, replyNumber=0, likeNumber=139, createdTime=2024-01-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=64c0808e0384, moduleTitle=Eur Heart J：盐皮质激素受体拮抗剂与房颤的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c0808e0384)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1706492, encodeId=1ffe1e0649240, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JACC：盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响, objectType=article, longId=301906, objectId=85dd3019062a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85dd3019062a, replyNumber=0, likeNumber=102, createdTime=2022-05-19, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85dd3019062a, moduleTitle=JACC：盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85dd3019062a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706490, encodeId=406b1e064905b, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JCEM：盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响, objectType=article, longId=210935, objectId=cad621093570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cad621093570, replyNumber=0, likeNumber=98, createdTime=2021-08-23, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cad621093570, moduleTitle=JCEM：盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cad621093570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706491, encodeId=ccae1e064917c, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JACC：抑制心肌重构，盐皮质激素受体拮抗剂对2型糖尿病患者做到了！, objectType=article, longId=215985, objectId=d21c21598511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21c21598511, replyNumber=0, likeNumber=100, createdTime=2022-06-27, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21c21598511, moduleTitle=JACC：抑制心肌重构，盐皮质激素受体拮抗剂对2型糖尿病患者做到了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d21c21598511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706489, encodeId=27641e06489c4, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JACC：美英法德跨国研究观察到盐皮质激素受体拮抗剂和恩帕格列净在心衰中的作用, objectType=article, longId=208709, objectId=4dfc208e0936, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dfc208e0936, replyNumber=0, likeNumber=103, createdTime=2022-03-03, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dfc208e0936, moduleTitle=JACC：美英法德跨国研究观察到盐皮质激素受体拮抗剂和恩帕格列净在心衰中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dfc208e0936)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706487, encodeId=d9b01e0648721, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JACC：美英法跨国研究 | 盐皮质激素受体拮抗剂治疗心衰患者的疗效, objectType=article, longId=205313, objectId=56fa20531308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56fa20531308, replyNumber=0, likeNumber=127, createdTime=2021-05-30, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56fa20531308, moduleTitle=JACC：美英法跨国研究 | 盐皮质激素受体拮抗剂治疗心衰患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56fa20531308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706488, encodeId=023f1e06488f5, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Hypertension：盐皮质激素受体拮抗剂对动脉僵硬度和内皮功能的影响, objectType=article, longId=206691, objectId=4e2a2066913a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e2a2066913a, replyNumber=0, likeNumber=89, createdTime=2021-08-01, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e2a2066913a, moduleTitle=Hypertension：盐皮质激素受体拮抗剂对动脉僵硬度和内皮功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e2a2066913a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706483, encodeId=d52f1e064831c, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Liver Int：盐皮质激素受体拮抗剂—Eplerenone意外地显著增加了HIV患者肝脏脂肪含量, objectType=article, longId=133897, objectId=097513389e59, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=097513389e59, replyNumber=0, likeNumber=102, createdTime=2018-09-27, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=097513389e59, moduleTitle=Liver Int：盐皮质激素受体拮抗剂—Eplerenone意外地显著增加了HIV患者肝脏脂肪含量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=097513389e59)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706486, encodeId=06b91e06486ef, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JAMA Cardiol：腹部肥胖患者使用盐皮质激素受体拮抗剂效果更佳, objectType=article, longId=147323, objectId=22f514e32309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22f514e32309, replyNumber=0, likeNumber=97, createdTime=2019-06-07, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22f514e32309, moduleTitle=JAMA Cardiol：腹部肥胖患者使用盐皮质激素受体拮抗剂效果更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22f514e32309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706485, encodeId=07881e06485bb, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JAHA：盐皮质激素受体拮抗剂可改善部分心梗和心衰患者预后, objectType=article, longId=142704, objectId=9448142e04d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9448142e04d8, replyNumber=0, likeNumber=100, createdTime=2018-08-21, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9448142e04d8, moduleTitle=JAHA：盐皮质激素受体拮抗剂可改善部分心梗和心衰患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9448142e04d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706484, encodeId=d0751e0648422, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Liver Int：盐皮质激素受体拮抗剂—eplerenone，可能不是治疗人类免疫缺陷病毒感染人群肝脂肪变性的有效方法, objectType=article, longId=138073, objectId=26641380e318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26641380e318, replyNumber=0, likeNumber=79, createdTime=2018-11-10, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26641380e318, moduleTitle=Liver Int：盐皮质激素受体拮抗剂—eplerenone，可能不是治疗人类免疫缺陷病毒感染人群肝脂肪变性的有效方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26641380e318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706480, encodeId=e04c1e06480db, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Am Heart J：盐皮质激素受体拮抗剂的高钾血症发生率究竟有多高？, objectType=article, longId=107606, objectId=b45010e60616, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b45010e60616, replyNumber=0, likeNumber=97, createdTime=2018-01-27, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b45010e60616, moduleTitle=Am Heart J：盐皮质激素受体拮抗剂的高钾血症发生率究竟有多高？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b45010e60616)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706482, encodeId=8c5f1e06482a4, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=JAHA：盐皮质激素受体拮抗剂可减少心衰患者再住院率, objectType=article, longId=124441, objectId=4bb112444114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb112444114, replyNumber=0, likeNumber=95, createdTime=2018-03-22, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb112444114, moduleTitle=JAHA：盐皮质激素受体拮抗剂可减少心衰患者再住院率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bb112444114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706481, encodeId=38191e0648164, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Eur J Heart Fail：心衰伴射血分数降低患者盐皮质激素受体拮抗剂的使用情况如何？, objectType=article, longId=118580, objectId=7182118580ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7182118580ac, replyNumber=0, likeNumber=91, createdTime=2018-01-30, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7182118580ac, moduleTitle=Eur J Heart Fail：心衰伴射血分数降低患者盐皮质激素受体拮抗剂的使用情况如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7182118580ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706479, encodeId=5c7e1e0647988, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Am J Kidney Dis：透析患者使用盐皮质激素受体拮抗剂安全吗？, objectType=article, longId=79266, objectId=9597e92666b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9597e92666b, replyNumber=0, likeNumber=97, createdTime=2017-05-01, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9597e92666b, moduleTitle=Am J Kidney Dis：透析患者使用盐皮质激素受体拮抗剂安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9597e92666b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706478, encodeId=80e11e064783d, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用, objectType=article, longId=43635, objectId=0e4e43635a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e4e43635a6, replyNumber=0, likeNumber=112, createdTime=2015-03-23, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e4e43635a6, moduleTitle=Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e4e43635a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1706477, encodeId=44cd1e06477be, content=<a href='/topic/show?id=0510e227652' target=_blank style='color:#2F92EE;'>#盐皮质激素受体拮抗剂#</a>, objectTitle=EHJ：高选择性盐皮质激素受体拮抗剂BAY 94-8862或更适用于心衰患者, objectType=article, longId=19685, objectId=ea3a19685bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea3a19685bd, replyNumber=0, likeNumber=132, createdTime=2014-03-15, rootId=0, userName=1194695146_61857357, userId=274b31274626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea3a19685bd, moduleTitle=EHJ：高选择性盐皮质激素受体拮抗剂BAY 94-8862或更适用于心衰患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea3a19685bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

盐皮质激素受体拮抗剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#心血管# #盐皮质激素受体拮抗剂# #不良心血管事件（MACE）#

Esc Heart Fail.：中国学者证实盐皮质激素受体拮抗剂在不同疾病条件下具有不同的心血管保护作用

2025-05-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#房颤# #盐皮质激素受体拮抗剂#

Eur Heart J：盐皮质激素受体拮抗剂与房颤的关系

2024-01-10发表于上海

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JACC：盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响

2022-05-19

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JCEM：盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响

2021-08-23

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JACC：抑制心肌重构，盐皮质激素受体拮抗剂对2型糖尿病患者做到了！

2022-06-27

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JACC：美英法德跨国研究观察到盐皮质激素受体拮抗剂和恩帕格列净在心衰中的作用

2022-03-03

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JACC：美英法跨国研究 | 盐皮质激素受体拮抗剂治疗心衰患者的疗效

2021-05-30

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Hypertension：盐皮质激素受体拮抗剂对动脉僵硬度和内皮功能的影响

2021-08-01

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Liver Int：盐皮质激素受体拮抗剂—Eplerenone意外地显著增加了HIV患者肝脏脂肪含量

2018-09-27

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JAMA Cardiol：腹部肥胖患者使用盐皮质激素受体拮抗剂效果更佳

2019-06-07

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JAHA：盐皮质激素受体拮抗剂可改善部分心梗和心衰患者预后

2018-08-21

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Liver Int：盐皮质激素受体拮抗剂—eplerenone，可能不是治疗人类免疫缺陷病毒感染人群肝脂肪变性的有效方法

2018-11-10

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Am Heart J：盐皮质激素受体拮抗剂的高钾血症发生率究竟有多高？

2018-01-27

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

JAHA：盐皮质激素受体拮抗剂可减少心衰患者再住院率

2018-03-22

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Eur J Heart Fail：心衰伴射血分数降低患者盐皮质激素受体拮抗剂的使用情况如何？

2018-01-30

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Am J Kidney Dis：透析患者使用盐皮质激素受体拮抗剂安全吗？

2017-05-01

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用

2015-03-23

1194695146_61857357 (审核中...)

前往app查看评论内容

#盐皮质激素受体拮抗剂#

EHJ：高选择性盐皮质激素受体拮抗剂BAY 94-8862或更适用于心衰患者

2014-03-15

科室
- - 订阅+
  - 更多科室
工具
服务